Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature

C Chatre, F Roubille, H Vernhet, C Jorgensen, YM Pers - Drug safety, 2018 - Springer
Introduction Chloroquine and hydroxychloroquine are widely used in the long-term
treatment of connective tissue disease and usually considered safe. However, chloroquine …

Cardiomyopathies due to left ventricular noncompaction, mitochondrial and storage diseases, and inborn errors of metabolism

JA Towbin, JL Jefferies - Circulation research, 2017 - Am Heart Assoc
The normal function of the human myocardium requires the proper generation and utilization
of energy and relies on a series of complex metabolic processes to achieve this normal …

[HTML][HTML] T1 mapping in cardiac MRI

D Radenkovic, S Weingärtner, L Ricketts, JC Moon… - Heart failure …, 2017 - Springer
Quantitative myocardial and blood T 1 have recently achieved clinical utility in numerous
pathologies, as they provide non-invasive tissue characterization with the potential to …

[HTML][HTML] Hypertrophic cardiomyopathy: genetics and clinical perspectives

CM Wolf - Cardiovascular diagnosis and therapy, 2019 - ncbi.nlm.nih.gov
Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and
defined by unexplained isolated progressive myocardial hypertrophy, systolic and diastolic …

Diagnosis and screening of patients with Fabry disease

I Vardarli, C Rischpler, K Herrmann… - … and clinical risk …, 2020 - Taylor & Francis
Fabry disease (FD) is an X-linked lysosomal storage disorder caused by absence or
deficient activity of α-galactosidase A (α-Gal A) due to mutations in the α-galactosidase A …

Lysosomal storage disorders affecting the heart: a review

V Nair, EC Belanger, JP Veinot - Cardiovascular Pathology, 2019 - Elsevier
Lysosomal storage disorders (LSD) comprise a group of diseases caused by a deficiency of
lysosomal enzymes, membrane transporters or other proteins involved in lysosomal biology …

[HTML][HTML] Anderson-Fabry disease cardiomyopathy: an update on epidemiology, diagnostic approach, management and monitoring strategies

T Averbuch, JA White, NM Fine - Frontiers in Cardiovascular Medicine, 2023 - frontiersin.org
Anderson-Fabry disease (AFD) is an X-linked lysosomal storage disorder caused by
deficient activity of the enzyme alpha-galactosidase. While AFD is recognized as a …

[HTML][HTML] Anderson–Fabry Disease: Red Flags for Early Diagnosis of Cardiac Involvement

A Iorio, F Luca, A Pozzi, CM Rao, C Chimenti… - Diagnostics, 2024 - mdpi.com
Anderson–Fabry disease (AFD) is a lysosome storage disorder resulting from an X-linked
inheritance of a mutation in the galactosidase A (GLA) gene encoding for the enzyme alpha …

[HTML][HTML] Anderson-Fabry disease in heart failure

MM Akhtar, PM Elliott - Biophysical Reviews, 2018 - Springer
Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by mutations in
the GLA gene that result in deficiency of the enzyme alpha-galactosidase A. The worldwide …

[HTML][HTML] The role of cardiovascular magnetic resonance imaging in heart failure

MA Peterzan, OJ Rider, LJ Anderson - Cardiac failure review, 2016 - ncbi.nlm.nih.gov
Cardiovascular imaging is key for the assessment of patients with heart failure. Today,
cardiovascular magnetic resonance imaging plays an established role in the assessment of …